TrialPLoS medicine2018
Nilvadipine in mild to moderate Alzheimer disease: A randomised controlled trial.
Brian Lawlor et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
79 papers cite itlatest 60 shown
this paperpooled ittrialcites it